20
Copperhead Investments Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SDM® 12, DILUTED NITROGLYCERIN USP, with a corresponding US DMF Number 25565.
Remarkably, this DMF maintains an Active status since its submission on December 06, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 01, 2014, and payment made on September 19, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II